Claim it free in under 5 minutes — verified by GSTIN, DigiLocker, or WhatsApp OTP. You control what buyers see, respond to inquiries, and post on RFQs.
Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. We are developing TSND-201 (methylone) as a rapid-acting and durable treatment for Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD), and other Central Nervous System (CNS) indications. Our leadership team has made pivotal contributions to 13 FDA approvals and $7B in M&A and public company value.
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Limited government data available — 5 criteria met
TRANSCEND THERAPEUTICS PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
Other verified manufacturers in the same network — discovered via MCA21 cross-references.